Soligenix
SNGX
#10401
Rank
ยฃ10.03 M
Marketcap
ยฃ0.97
Share price
-1.73%
Change (1 day)
-37.54%
Change (1 year)

EPS for Soligenix (SNGX)

EPS in 2025 (TTM): -ยฃ2.43

According to Soligenix's latest financial reports the company's current EPS (TTM) is -ยฃ2.40. In 2024 the company made an earnings per share (EPS) of -ยฃ3.68 an increase over its 2023 EPS that were of -ยฃ9.36.

EPS history for Soligenix from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ2.43-33.98%
2024-ยฃ3.68-60.66%
2023-ยฃ9.36-83.55%
2022-ยฃ56.9313.95%
2021-ยฃ49.96-56.03%
2020-ยฃ113.6233.33%
2019-ยฃ85.22-29.41%
2018-ยฃ120.72-41.38%
2017-ยฃ205.9424.73%
2016-ยฃ165.11-69%
2015-ยฃ532.60-6.25%
2014-ยฃ568.11-50.77%
2013-ยฃ1,15475.68%
2012-ยฃ656.8868.18%
2011-ยฃ390.58-69.86%
2010-ยฃ1,296-8.75%
2009-ยฃ1,42033.33%
2008-ยฃ1,065-57.14%
2007-ยฃ2,485-46.15%
2006-ยฃ4,61644.44%
2005-ยฃ3,196-40.7%
2004-ยฃ5,389-15.62%
2003-ยฃ6,387-25.52%
2002-ยฃ8,576-80.94%
2001-ยฃ44,991160.89%
2000-ยฃ17,245-40.57%
1999-ยฃ29,016-63.84%
1998-ยฃ80,245601.73%
1997-ยฃ11,435101.7%
1996-ยฃ5,670

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ8.24-443.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ1.01-141.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ1.53-163.74%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-ยฃ0.70-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ1.50-37.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.92-138.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Emergent BioSolutions
EBS
ยฃ1.04-143.52%๐Ÿ‡บ๐Ÿ‡ธ USA